Antimicrobial activity of lidocaine against bacteria associated with nosocomial wound infection

Annals of Plastic Surgery

Volumn 43, Issue 3, 1999, Pages 239-245

  Parr, A M ^a   Zoutman, D E ^a   Davidson, J S D ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b HOTEL DIEU HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; LIDOCAINE; LOCAL ANESTHETIC AGENT; METICILLIN; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SENSITIVITY; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; WOUND INFECTION;

EID: 0032828926     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000637-199909000-00003     Document Type: Article

References (18)

1. Jonnesco T. Remarks on general spinal anesthesia. BMJ 1909;2:1396-1401
2. Edlich RF, Rodeheaver GT, Thacher JF. Technical factors in the prevention of wound infections. In: Howard RJ, Simmons RL, eds. Surgical infectious diseases. 2nd ed. Norwalk, CT: Appleton and Lange, 1988:331-350
3. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991;91(suppl 3B):72-75
4. Moellering RC. Emergence of enterococcus as a significant pathogen. Clin Infect Dis 1992;14:1173-1178
5. Kenberg HD. Antimicrobial susceptibility testing; tests to assess bactericidal activity. In: Isenberg HD, ed. Clinical microbiology procedures handbook. Washington, DC: American Society for Microbiology, 1992:5.16:1-32.
6. Murphy JT, Allen HF, Mangiaracine AB. Preparation, sterilization, and preservation of ophthalmic solutions. Arch Ophthalmol 1955;53:63-78
7. Schmidt RM, Rosenkranz HS. Antimicrobial activity of topical anesthetics: lidocaine and procaine. J Infect Dis 1970;121:597-607
8. Badenoch PR, Coster DJ. Antimicrobial activity of topical anesthetic preparations. Br J Ophthalmol 1982;66:364-367
9. Wimberley N, Willey S, Sullivan N, et al. Antibacterial properties of lidocaine. Chest 1979;76:37-40
10. Miller MA, Shelley WB. Antibacterial properties of lidocaine on bacteria isolated from dermal lesions. Arch Dermatol 1985;121:1157-1159
11. Craig SB, Concannon MJ, McDonald GA, Puckett CL. The antibacterial effects of tumescent liposuction fluid. Plast Reconstr Surg 1999;103(2):666-670
12. Ohsuka S, Ohta M, Masuda K, et al. Lidocaine hydrochloride and acetylsalicylate kill bacteria by disrupting the bacterial membrane potential in different ways. Microbiol Immunol 1994;38(6):429-434
13. Alastair JJ, Wood MD. Antimicrobial-drug resistance. Drug Ther 1996;335(19):1445-1453
14. Leclerq R, Courvalin P. Resistance to glycopeptides in enterococci. Clin Infect Dis 1997;24:545-556
15. Thompson KD, Welykyj S, Massa MC. Antibacterial activity of lidocaine in combination with a bicarbonate buffer. J Dermatol Surg Oncol 1993;19:216-220
16. Barker W, Rodeheaver GT, Edgerton MT, Edlich RF. Damage to tissue defenses by a topical anesthetic agent. Ann Emerg Med 1982;11:307-310
17. Krizek TJ, Robson M. Bacterial growth and skin graft survival. Surg Forum 1967;18:518-519
18. Robson MC, Lea CE, Dalton JB, et al. Quantitative bacteriology and delayed wound closure. Surg Forum 1968;19: 501-502